Download PDF
1 / Pages

Other users also viewed these articles

Immune checkpoint and angiogenic inhibitors for the treatment of hepatocellular carcinoma: It takes two to tangle Caecilia Sukowati; Loraine Kay D. Cabral; Claudio Tiribelli;
Ann Hepatol. 2022;27:
Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma Federico Piñero; Mario Tanno; Gabriel Aballay Soteras; Matías Tisi Baña; Melisa Dirchwolf; Eduardo Fassio; Andrés Ruf; Silvia Mengarelli; Silvia Borzi; Nora Fernández; Ezequiel Ridruejo; Valeria Descalzi; Margarita Anders; Guillermo Mazzolini; Virginia Reggiardo; Sebastián Marciano; Florencia Perazzo; Juan Carlos Spina; Lucas McCormack; Martín Maraschio; Cecilia Lagues; Adrián Gadano; Federico Villamil; Marcelo Silva; Fernando Cairo; Beatriz Ameigeiras;
Ann Hepatol. 2020;19:546-69
Progress of targeted and immunotherapy for hepatocellular carcinoma and the application of next-generation sequencing Fan Yang; Kaige Deng; Haoran Zheng; Zhenting Liu; Yongchang Zheng;
10.1016/j.aohep.2022.100677